Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-22-006278

Head of Pharm Ops and Tech gave up 110 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 371 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2022-02-18 Option exercise +371 1,767.89 D: show line 1 in the form
Murphy Nicole Head of Pharm Ops and Tech 2022-02-18 Shares withheld for taxes −110 $209.79 $23,077 1,657.89 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2022-02-18 Option exercise · Restricted Stock Unit −371 2,349 D: show line 3 in the form
Murphy Nicole Head of Pharm Ops and Tech 2022-02-18 Other disposition · Restricted Stock Unit −535 1,814 D: show line 4 in the form
Loading xslF345X03/form4.xml…